A detailed history of Independent Advisor Alliance transactions in Boston Scientific Corp stock. As of the latest transaction made, Independent Advisor Alliance holds 6,233 shares of BSX stock, worth $526,937. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,233
Previous 4,894 27.36%
Holding current value
$526,937
Previous $335,000 43.28%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$67.33 - $77.71 $90,154 - $104,053
1,339 Added 27.36%
6,233 $480,000
Q1 2024

May 08, 2024

BUY
$57.6 - $68.62 $54,604 - $65,051
948 Added 24.02%
4,894 $335,000
Q4 2023

Feb 08, 2024

BUY
$48.64 - $57.81 $191,933 - $228,118
3,946 New
3,946 $228,000
Q2 2021

Aug 12, 2021

SELL
$38.58 - $44.24 $407,211 - $466,953
-10,555 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $15,130 - $17,018
-429 Reduced 3.91%
10,555 $408,000
Q4 2020

Feb 11, 2021

SELL
$33.15 - $41.97 $13,094 - $16,578
-395 Reduced 3.47%
10,984 $395,000
Q3 2020

Nov 04, 2020

SELL
$34.44 - $42.23 $14,120 - $17,314
-410 Reduced 3.48%
11,379 $435,000
Q2 2020

Aug 06, 2020

BUY
$30.19 - $39.11 $77,829 - $100,825
2,578 Added 27.99%
11,789 $414,000
Q1 2020

May 14, 2020

BUY
$25.83 - $45.71 $25,855 - $45,755
1,001 Added 12.19%
9,211 $301,000
Q4 2019

Feb 07, 2020

SELL
$37.87 - $45.37 $8,710 - $10,435
-230 Reduced 2.73%
8,210 $371,000
Q3 2019

Nov 12, 2019

BUY
$40.31 - $43.45 $16,003 - $17,249
397 Added 4.94%
8,440 $343,000
Q2 2019

Aug 12, 2019

BUY
$34.91 - $42.98 $10,298 - $12,679
295 Added 3.81%
8,043 $346,000
Q1 2019

May 07, 2019

BUY
$32.91 - $40.75 $254,986 - $315,731
7,748 New
7,748 $297,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Independent Advisor Alliance Portfolio

Follow Independent Advisor Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.